MoneyWorks4Me

Earum Pharmaceuticals informs about compliance certificate

14 Jul 2021 Evaluate
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Earum Pharmaceuticals has informed that it submitted certificate for the quarter ended June 30, 2021 received from Bigshare Services, Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers